Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibitionGabrielle S. Wong, Adam J. Bass, Jin Zhou et al.|Nature Medicine|2018Cited by 282
CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinomaJin Zhou, Adam J. Bass|Nature Communications|2017Cited by 78
Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast CancerChengheng Liao, Qing Zhang, Giada Zurlo et al.|Cancer Discovery|2020Cited by 68
Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibitionGabrielle S. Wong, Adam J. Bass, Jin Zhou et al.|Nature Medicine|2018Cited by 10